Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Schizophrenia and Valproate
1
x
$
30.00
R. Bart Sangal, MD: What Is a Significant Response in Drug Studies of Attention- Deficit/Hyperactivity Disorder: Statistical Significance Is Necessary, But Is It Sufficient?
1
x
$
30.00
Financial Incentives to Improve Adherence to Medication in Five Patients with Schizophrenia in The Netherlands
1
x
$
30.00
P. Murali Doraiswamy, MD: Donepezil for Cognitive Decline Following Coronary Artery Bypass Surgery: A Pilot Randomized Controlled Trial
1
x
$
30.00
Efficacy of Omega-3 Fatty Acids in Mood Disorders
1
x
$
30.00
Mark S. Bauer, MD: Brief Report: Paroxetine in Younger and Adult Individuals at High Risk for Suicide
1
x
$
30.00
Neuropharmacology of Paroxetine
1
x
$
30.00
View Cart
Checkout
Home
divalproex-sodium
You cannot add another "Schizophrenia and Valproate" to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Valproate Use in Neuropsychiatric Disorders in the Elderly
$
30.00
Add to cart
Details
Divalproex in the Treatment of Migraine
$
30.00
Add to cart
Details
The Use of Divalproex in the Treatment of Addictive Disorders
$
30.00
Add to cart
Details
Schizophrenia and Valproate
$
30.00
Add to cart
Details
The Efficacy of Divalproex for Partial Epilepsies
$
30.00
Add to cart
Details
Pharmacokinetics, Drug Interactions, and Tolerability of Valproate
$
30.00
Add to cart
Details
Page load link
Go to Top
